Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Pharmaceutical Intermediates market report explains the definition, types, applications, major countries, and major players of the Pharmaceutical Intermediates market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Granules
Alpha
Jiuzhou
Chemcon
Porton
Ganesh
Lianhetech
Patheon
Catalent
Jubilant
Tianma
ABA Chem
Jiujiujiu
BASF
Yongtai
Lonza
By Type:
GMP
Non-GMP
By End-User:
Antibiotics
Antipyretic Analgesics
Vitamins
Others
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Pharmaceutical Intermediates Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Pharmaceutical Intermediates Outlook to 2028- Original Forecasts
-
2.2 Pharmaceutical Intermediates Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Pharmaceutical Intermediates Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Pharmaceutical Intermediates Market- Recent Developments
-
6.1 Pharmaceutical Intermediates Market News and Developments
-
6.2 Pharmaceutical Intermediates Market Deals Landscape
7 Pharmaceutical Intermediates Raw Materials and Cost Structure Analysis
-
7.1 Pharmaceutical Intermediates Key Raw Materials
-
7.2 Pharmaceutical Intermediates Price Trend of Key Raw Materials
-
7.3 Pharmaceutical Intermediates Key Suppliers of Raw Materials
-
7.4 Pharmaceutical Intermediates Market Concentration Rate of Raw Materials
-
7.5 Pharmaceutical Intermediates Cost Structure Analysis
-
7.5.1 Pharmaceutical Intermediates Raw Materials Analysis
-
7.5.2 Pharmaceutical Intermediates Labor Cost Analysis
-
7.5.3 Pharmaceutical Intermediates Manufacturing Expenses Analysis
8 Global Pharmaceutical Intermediates Import and Export Analysis (Top 10 Countries)
-
8.1 Global Pharmaceutical Intermediates Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Pharmaceutical Intermediates Export by Region (Top 10 Countries) (2017-2028)
9 Global Pharmaceutical Intermediates Market Outlook by Types and Applications to 2022
-
9.1 Global Pharmaceutical Intermediates Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global GMP Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Non-GMP Consumption and Growth Rate (2017-2022)
-
9.2 Global Pharmaceutical Intermediates Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Antibiotics Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Antipyretic Analgesics Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Vitamins Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Others Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Pharmaceutical Intermediates Market Analysis and Outlook till 2022
-
10.1 Global Pharmaceutical Intermediates Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Pharmaceutical Intermediates Consumption (2017-2022)
-
10.2.2 Canada Pharmaceutical Intermediates Consumption (2017-2022)
-
10.2.3 Mexico Pharmaceutical Intermediates Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Pharmaceutical Intermediates Consumption (2017-2022)
-
10.3.2 UK Pharmaceutical Intermediates Consumption (2017-2022)
-
10.3.3 Spain Pharmaceutical Intermediates Consumption (2017-2022)
-
10.3.4 Belgium Pharmaceutical Intermediates Consumption (2017-2022)
-
10.3.5 France Pharmaceutical Intermediates Consumption (2017-2022)
-
10.3.6 Italy Pharmaceutical Intermediates Consumption (2017-2022)
-
10.3.7 Denmark Pharmaceutical Intermediates Consumption (2017-2022)
-
10.3.8 Finland Pharmaceutical Intermediates Consumption (2017-2022)
-
10.3.9 Norway Pharmaceutical Intermediates Consumption (2017-2022)
-
10.3.10 Sweden Pharmaceutical Intermediates Consumption (2017-2022)
-
10.3.11 Poland Pharmaceutical Intermediates Consumption (2017-2022)
-
10.3.12 Russia Pharmaceutical Intermediates Consumption (2017-2022)
-
10.3.13 Turkey Pharmaceutical Intermediates Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Pharmaceutical Intermediates Consumption (2017-2022)
-
10.4.2 Japan Pharmaceutical Intermediates Consumption (2017-2022)
-
10.4.3 India Pharmaceutical Intermediates Consumption (2017-2022)
-
10.4.4 South Korea Pharmaceutical Intermediates Consumption (2017-2022)
-
10.4.5 Pakistan Pharmaceutical Intermediates Consumption (2017-2022)
-
10.4.6 Bangladesh Pharmaceutical Intermediates Consumption (2017-2022)
-
10.4.7 Indonesia Pharmaceutical Intermediates Consumption (2017-2022)
-
10.4.8 Thailand Pharmaceutical Intermediates Consumption (2017-2022)
-
10.4.9 Singapore Pharmaceutical Intermediates Consumption (2017-2022)
-
10.4.10 Malaysia Pharmaceutical Intermediates Consumption (2017-2022)
-
10.4.11 Philippines Pharmaceutical Intermediates Consumption (2017-2022)
-
10.4.12 Vietnam Pharmaceutical Intermediates Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Pharmaceutical Intermediates Consumption (2017-2022)
-
10.5.2 Colombia Pharmaceutical Intermediates Consumption (2017-2022)
-
10.5.3 Chile Pharmaceutical Intermediates Consumption (2017-2022)
-
10.5.4 Argentina Pharmaceutical Intermediates Consumption (2017-2022)
-
10.5.5 Venezuela Pharmaceutical Intermediates Consumption (2017-2022)
-
10.5.6 Peru Pharmaceutical Intermediates Consumption (2017-2022)
-
10.5.7 Puerto Rico Pharmaceutical Intermediates Consumption (2017-2022)
-
10.5.8 Ecuador Pharmaceutical Intermediates Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Pharmaceutical Intermediates Consumption (2017-2022)
-
10.6.2 Kuwait Pharmaceutical Intermediates Consumption (2017-2022)
-
10.6.3 Oman Pharmaceutical Intermediates Consumption (2017-2022)
-
10.6.4 Qatar Pharmaceutical Intermediates Consumption (2017-2022)
-
10.6.5 Saudi Arabia Pharmaceutical Intermediates Consumption (2017-2022)
-
10.6.6 United Arab Emirates Pharmaceutical Intermediates Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Pharmaceutical Intermediates Consumption (2017-2022)
-
10.7.2 South Africa Pharmaceutical Intermediates Consumption (2017-2022)
-
10.7.3 Egypt Pharmaceutical Intermediates Consumption (2017-2022)
-
10.7.4 Algeria Pharmaceutical Intermediates Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Pharmaceutical Intermediates Consumption (2017-2022)
-
10.8.2 New Zealand Pharmaceutical Intermediates Consumption (2017-2022)
11 Global Pharmaceutical Intermediates Competitive Analysis
-
11.1 Granules
-
11.1.1 Granules Company Details
-
11.1.2 Granules Pharmaceutical Intermediates Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Granules Pharmaceutical Intermediates Main Business and Markets Served
-
11.1.4 Granules Pharmaceutical Intermediates Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Alpha
-
11.2.1 Alpha Company Details
-
11.2.2 Alpha Pharmaceutical Intermediates Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Alpha Pharmaceutical Intermediates Main Business and Markets Served
-
11.2.4 Alpha Pharmaceutical Intermediates Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Jiuzhou
-
11.3.1 Jiuzhou Company Details
-
11.3.2 Jiuzhou Pharmaceutical Intermediates Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Jiuzhou Pharmaceutical Intermediates Main Business and Markets Served
-
11.3.4 Jiuzhou Pharmaceutical Intermediates Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Chemcon
-
11.4.1 Chemcon Company Details
-
11.4.2 Chemcon Pharmaceutical Intermediates Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Chemcon Pharmaceutical Intermediates Main Business and Markets Served
-
11.4.4 Chemcon Pharmaceutical Intermediates Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Porton
-
11.5.1 Porton Company Details
-
11.5.2 Porton Pharmaceutical Intermediates Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Porton Pharmaceutical Intermediates Main Business and Markets Served
-
11.5.4 Porton Pharmaceutical Intermediates Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 Ganesh
-
11.6.1 Ganesh Company Details
-
11.6.2 Ganesh Pharmaceutical Intermediates Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 Ganesh Pharmaceutical Intermediates Main Business and Markets Served
-
11.6.4 Ganesh Pharmaceutical Intermediates Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 Lianhetech
-
11.7.1 Lianhetech Company Details
-
11.7.2 Lianhetech Pharmaceutical Intermediates Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 Lianhetech Pharmaceutical Intermediates Main Business and Markets Served
-
11.7.4 Lianhetech Pharmaceutical Intermediates Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Patheon
-
11.8.1 Patheon Company Details
-
11.8.2 Patheon Pharmaceutical Intermediates Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Patheon Pharmaceutical Intermediates Main Business and Markets Served
-
11.8.4 Patheon Pharmaceutical Intermediates Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 Catalent
-
11.9.1 Catalent Company Details
-
11.9.2 Catalent Pharmaceutical Intermediates Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 Catalent Pharmaceutical Intermediates Main Business and Markets Served
-
11.9.4 Catalent Pharmaceutical Intermediates Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 Jubilant
-
11.10.1 Jubilant Company Details
-
11.10.2 Jubilant Pharmaceutical Intermediates Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 Jubilant Pharmaceutical Intermediates Main Business and Markets Served
-
11.10.4 Jubilant Pharmaceutical Intermediates Product Portfolio
-
11.10.5 Recent Research and Development Strategies
-
11.11 Tianma
-
11.11.1 Tianma Company Details
-
11.11.2 Tianma Pharmaceutical Intermediates Sales, Price, Value and Gross Profit (2017-2022)
-
11.11.3 Tianma Pharmaceutical Intermediates Main Business and Markets Served
-
11.11.4 Tianma Pharmaceutical Intermediates Product Portfolio
-
11.11.5 Recent Research and Development Strategies
-
11.12 ABA Chem
-
11.12.1 ABA Chem Company Details
-
11.12.2 ABA Chem Pharmaceutical Intermediates Sales, Price, Value and Gross Profit (2017-2022)
-
11.12.3 ABA Chem Pharmaceutical Intermediates Main Business and Markets Served
-
11.12.4 ABA Chem Pharmaceutical Intermediates Product Portfolio
-
11.12.5 Recent Research and Development Strategies
-
11.13 Jiujiujiu
-
11.13.1 Jiujiujiu Company Details
-
11.13.2 Jiujiujiu Pharmaceutical Intermediates Sales, Price, Value and Gross Profit (2017-2022)
-
11.13.3 Jiujiujiu Pharmaceutical Intermediates Main Business and Markets Served
-
11.13.4 Jiujiujiu Pharmaceutical Intermediates Product Portfolio
-
11.13.5 Recent Research and Development Strategies
-
11.14 BASF
-
11.14.1 BASF Company Details
-
11.14.2 BASF Pharmaceutical Intermediates Sales, Price, Value and Gross Profit (2017-2022)
-
11.14.3 BASF Pharmaceutical Intermediates Main Business and Markets Served
-
11.14.4 BASF Pharmaceutical Intermediates Product Portfolio
-
11.14.5 Recent Research and Development Strategies
-
11.15 Yongtai
-
11.15.1 Yongtai Company Details
-
11.15.2 Yongtai Pharmaceutical Intermediates Sales, Price, Value and Gross Profit (2017-2022)
-
11.15.3 Yongtai Pharmaceutical Intermediates Main Business and Markets Served
-
11.15.4 Yongtai Pharmaceutical Intermediates Product Portfolio
-
11.15.5 Recent Research and Development Strategies
-
11.16 Lonza
-
11.16.1 Lonza Company Details
-
11.16.2 Lonza Pharmaceutical Intermediates Sales, Price, Value and Gross Profit (2017-2022)
-
11.16.3 Lonza Pharmaceutical Intermediates Main Business and Markets Served
-
11.16.4 Lonza Pharmaceutical Intermediates Product Portfolio
-
11.16.5 Recent Research and Development Strategies
12 Global Pharmaceutical Intermediates Market Outlook by Types and Applications to 2028
-
12.1 Global Pharmaceutical Intermediates Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global GMP Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Non-GMP Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Pharmaceutical Intermediates Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Antibiotics Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Antipyretic Analgesics Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Vitamins Consumption Forecast and Growth Rate (2022-2028)
-
12.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Pharmaceutical Intermediates Market Analysis and Outlook to 2028
-
13.1 Global Pharmaceutical Intermediates Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Pharmaceutical Intermediates Consumption Forecast (2022-2028)
-
13.2.2 Canada Pharmaceutical Intermediates Consumption Forecast (2022-2028)
-
13.2.3 Mexico Pharmaceutical Intermediates Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Pharmaceutical Intermediates Consumption Forecast (2022-2028)
-
13.3.2 UK Pharmaceutical Intermediates Consumption Forecast (2022-2028)
-
13.3.3 Spain Pharmaceutical Intermediates Consumption Forecast (2022-2028)
-
13.3.4 Belgium Pharmaceutical Intermediates Consumption Forecast (2022-2028)
-
13.3.5 France Pharmaceutical Intermediates Consumption Forecast (2022-2028)
-
13.3.6 Italy Pharmaceutical Intermediates Consumption Forecast (2022-2028)
-
13.3.7 Denmark Pharmaceutical Intermediates Consumption Forecast (2022-2028)
-
13.3.8 Finland Pharmaceutical Intermediates Consumption Forecast (2022-2028)
-
13.3.9 Norway Pharmaceutical Intermediates Consumption Forecast (2022-2028)
-
13.3.10 Sweden Pharmaceutical Intermediates Consumption Forecast (2022-2028)
-
13.3.11 Poland Pharmaceutical Intermediates Consumption Forecast (2022-2028)
-
13.3.12 Russia Pharmaceutical Intermediates Consumption Forecast (2022-2028)
-
13.3.13 Turkey Pharmaceutical Intermediates Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Pharmaceutical Intermediates Consumption Forecast (2022-2028)
-
13.4.2 Japan Pharmaceutical Intermediates Consumption Forecast (2022-2028)
-
13.4.3 India Pharmaceutical Intermediates Consumption Forecast (2022-2028)
-
13.4.4 South Korea Pharmaceutical Intermediates Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Pharmaceutical Intermediates Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Pharmaceutical Intermediates Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Pharmaceutical Intermediates Consumption Forecast (2022-2028)
-
13.4.8 Thailand Pharmaceutical Intermediates Consumption Forecast (2022-2028)
-
13.4.9 Singapore Pharmaceutical Intermediates Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Pharmaceutical Intermediates Consumption Forecast (2022-2028)
-
13.4.11 Philippines Pharmaceutical Intermediates Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Pharmaceutical Intermediates Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Pharmaceutical Intermediates Consumption Forecast (2022-2028)
-
13.5.2 Colombia Pharmaceutical Intermediates Consumption Forecast (2022-2028)
-
13.5.3 Chile Pharmaceutical Intermediates Consumption Forecast (2022-2028)
-
13.5.4 Argentina Pharmaceutical Intermediates Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Pharmaceutical Intermediates Consumption Forecast (2022-2028)
-
13.5.6 Peru Pharmaceutical Intermediates Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Pharmaceutical Intermediates Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Pharmaceutical Intermediates Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Pharmaceutical Intermediates Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Pharmaceutical Intermediates Consumption Forecast (2022-2028)
-
13.6.3 Oman Pharmaceutical Intermediates Consumption Forecast (2022-2028)
-
13.6.4 Qatar Pharmaceutical Intermediates Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Pharmaceutical Intermediates Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Pharmaceutical Intermediates Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Pharmaceutical Intermediates Consumption Forecast (2022-2028)
-
13.7.2 South Africa Pharmaceutical Intermediates Consumption Forecast (2022-2028)
-
13.7.3 Egypt Pharmaceutical Intermediates Consumption Forecast (2022-2028)
-
13.7.4 Algeria Pharmaceutical Intermediates Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Pharmaceutical Intermediates Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Pharmaceutical Intermediates Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Pharmaceutical Intermediates
-
Figure of Pharmaceutical Intermediates Picture
-
Table Global Pharmaceutical Intermediates Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Pharmaceutical Intermediates Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global GMP Consumption and Growth Rate (2017-2022)
-
Figure Global Non-GMP Consumption and Growth Rate (2017-2022)
-
Figure Global Antibiotics Consumption and Growth Rate (2017-2022)
-
Figure Global Antipyretic Analgesics Consumption and Growth Rate (2017-2022)
-
Figure Global Vitamins Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Pharmaceutical Intermediates Consumption by Country (2017-2022)
-
Table North America Pharmaceutical Intermediates Consumption by Country (2017-2022)
-
Figure United States Pharmaceutical Intermediates Consumption and Growth Rate (2017-2022)
-
Figure Canada Pharmaceutical Intermediates Consumption and Growth Rate (2017-2022)
-
Figure Mexico Pharmaceutical Intermediates Consumption and Growth Rate (2017-2022)
-
Table Europe Pharmaceutical Intermediates Consumption by Country (2017-2022)
-
Figure Germany Pharmaceutical Intermediates Consumption and Growth Rate (2017-2022)
-
Figure UK Pharmaceutical Intermediates Consumption and Growth Rate (2017-2022)
-
Figure Spain Pharmaceutical Intermediates Consumption and Growth Rate (2017-2022)
-
Figure Belgium Pharmaceutical Intermediates Consumption and Growth Rate (2017-2022)
-
Figure France Pharmaceutical Intermediates Consumption and Growth Rate (2017-2022)
-
Figure Italy Pharmaceutical Intermediates Consumption and Growth Rate (2017-2022)
-
Figure Denmark Pharmaceutical Intermediates Consumption and Growth Rate (2017-2022)
-
Figure Finland Pharmaceutical Intermediates Consumption and Growth Rate (2017-2022)
-
Figure Norway Pharmaceutical Intermediates Consumption and Growth Rate (2017-2022)
-
Figure Sweden Pharmaceutical Intermediates Consumption and Growth Rate (2017-2022)
-
Figure Poland Pharmaceutical Intermediates Consumption and Growth Rate (2017-2022)
-
Figure Russia Pharmaceutical Intermediates Consumption and Growth Rate (2017-2022)
-
Figure Turkey Pharmaceutical Intermediates Consumption and Growth Rate (2017-2022)
-
Table APAC Pharmaceutical Intermediates Consumption by Country (2017-2022)
-
Figure China Pharmaceutical Intermediates Consumption and Growth Rate (2017-2022)
-
Figure Japan Pharmaceutical Intermediates Consumption and Growth Rate (2017-2022)
-
Figure India Pharmaceutical Intermediates Consumption and Growth Rate (2017-2022)
-
Figure South Korea Pharmaceutical Intermediates Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Pharmaceutical Intermediates Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Pharmaceutical Intermediates Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Pharmaceutical Intermediates Consumption and Growth Rate (2017-2022)
-
Figure Thailand Pharmaceutical Intermediates Consumption and Growth Rate (2017-2022)
-
Figure Singapore Pharmaceutical Intermediates Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Pharmaceutical Intermediates Consumption and Growth Rate (2017-2022)
-
Figure Philippines Pharmaceutical Intermediates Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Pharmaceutical Intermediates Consumption and Growth Rate (2017-2022)
-
Table South America Pharmaceutical Intermediates Consumption by Country (2017-2022)
-
Figure Brazil Pharmaceutical Intermediates Consumption and Growth Rate (2017-2022)
-
Figure Colombia Pharmaceutical Intermediates Consumption and Growth Rate (2017-2022)
-
Figure Chile Pharmaceutical Intermediates Consumption and Growth Rate (2017-2022)
-
Figure Argentina Pharmaceutical Intermediates Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Pharmaceutical Intermediates Consumption and Growth Rate (2017-2022)
-
Figure Peru Pharmaceutical Intermediates Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Pharmaceutical Intermediates Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Pharmaceutical Intermediates Consumption and Growth Rate (2017-2022)
-
Table GCC Pharmaceutical Intermediates Consumption by Country (2017-2022)
-
Figure Bahrain Pharmaceutical Intermediates Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Pharmaceutical Intermediates Consumption and Growth Rate (2017-2022)
-
Figure Oman Pharmaceutical Intermediates Consumption and Growth Rate (2017-2022)
-
Figure Qatar Pharmaceutical Intermediates Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Pharmaceutical Intermediates Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Pharmaceutical Intermediates Consumption and Growth Rate (2017-2022)
-
Table Africa Pharmaceutical Intermediates Consumption by Country (2017-2022)
-
Figure Nigeria Pharmaceutical Intermediates Consumption and Growth Rate (2017-2022)
-
Figure South Africa Pharmaceutical Intermediates Consumption and Growth Rate (2017-2022)
-
Figure Egypt Pharmaceutical Intermediates Consumption and Growth Rate (2017-2022)
-
Figure Algeria Pharmaceutical Intermediates Consumption and Growth Rate (2017-2022)
-
Table Oceania Pharmaceutical Intermediates Consumption by Country (2017-2022)
-
Figure Australia Pharmaceutical Intermediates Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Pharmaceutical Intermediates Consumption and Growth Rate (2017-2022)
-
Table Granules Company Details
-
Table Granules Pharmaceutical Intermediates Sales, Price, Value and Gross Profit (2017-2022)
-
Table Granules Pharmaceutical Intermediates Main Business and Markets Served
-
Table Granules Pharmaceutical Intermediates Product Portfolio
-
Table Alpha Company Details
-
Table Alpha Pharmaceutical Intermediates Sales, Price, Value and Gross Profit (2017-2022)
-
Table Alpha Pharmaceutical Intermediates Main Business and Markets Served
-
Table Alpha Pharmaceutical Intermediates Product Portfolio
-
Table Jiuzhou Company Details
-
Table Jiuzhou Pharmaceutical Intermediates Sales, Price, Value and Gross Profit (2017-2022)
-
Table Jiuzhou Pharmaceutical Intermediates Main Business and Markets Served
-
Table Jiuzhou Pharmaceutical Intermediates Product Portfolio
-
Table Chemcon Company Details
-
Table Chemcon Pharmaceutical Intermediates Sales, Price, Value and Gross Profit (2017-2022)
-
Table Chemcon Pharmaceutical Intermediates Main Business and Markets Served
-
Table Chemcon Pharmaceutical Intermediates Product Portfolio
-
Table Porton Company Details
-
Table Porton Pharmaceutical Intermediates Sales, Price, Value and Gross Profit (2017-2022)
-
Table Porton Pharmaceutical Intermediates Main Business and Markets Served
-
Table Porton Pharmaceutical Intermediates Product Portfolio
-
Table Ganesh Company Details
-
Table Ganesh Pharmaceutical Intermediates Sales, Price, Value and Gross Profit (2017-2022)
-
Table Ganesh Pharmaceutical Intermediates Main Business and Markets Served
-
Table Ganesh Pharmaceutical Intermediates Product Portfolio
-
Table Lianhetech Company Details
-
Table Lianhetech Pharmaceutical Intermediates Sales, Price, Value and Gross Profit (2017-2022)
-
Table Lianhetech Pharmaceutical Intermediates Main Business and Markets Served
-
Table Lianhetech Pharmaceutical Intermediates Product Portfolio
-
Table Patheon Company Details
-
Table Patheon Pharmaceutical Intermediates Sales, Price, Value and Gross Profit (2017-2022)
-
Table Patheon Pharmaceutical Intermediates Main Business and Markets Served
-
Table Patheon Pharmaceutical Intermediates Product Portfolio
-
Table Catalent Company Details
-
Table Catalent Pharmaceutical Intermediates Sales, Price, Value and Gross Profit (2017-2022)
-
Table Catalent Pharmaceutical Intermediates Main Business and Markets Served
-
Table Catalent Pharmaceutical Intermediates Product Portfolio
-
Table Jubilant Company Details
-
Table Jubilant Pharmaceutical Intermediates Sales, Price, Value and Gross Profit (2017-2022)
-
Table Jubilant Pharmaceutical Intermediates Main Business and Markets Served
-
Table Jubilant Pharmaceutical Intermediates Product Portfolio
-
Table Tianma Company Details
-
Table Tianma Pharmaceutical Intermediates Sales, Price, Value and Gross Profit (2017-2022)
-
Table Tianma Pharmaceutical Intermediates Main Business and Markets Served
-
Table Tianma Pharmaceutical Intermediates Product Portfolio
-
Table ABA Chem Company Details
-
Table ABA Chem Pharmaceutical Intermediates Sales, Price, Value and Gross Profit (2017-2022)
-
Table ABA Chem Pharmaceutical Intermediates Main Business and Markets Served
-
Table ABA Chem Pharmaceutical Intermediates Product Portfolio
-
Table Jiujiujiu Company Details
-
Table Jiujiujiu Pharmaceutical Intermediates Sales, Price, Value and Gross Profit (2017-2022)
-
Table Jiujiujiu Pharmaceutical Intermediates Main Business and Markets Served
-
Table Jiujiujiu Pharmaceutical Intermediates Product Portfolio
-
Table BASF Company Details
-
Table BASF Pharmaceutical Intermediates Sales, Price, Value and Gross Profit (2017-2022)
-
Table BASF Pharmaceutical Intermediates Main Business and Markets Served
-
Table BASF Pharmaceutical Intermediates Product Portfolio
-
Table Yongtai Company Details
-
Table Yongtai Pharmaceutical Intermediates Sales, Price, Value and Gross Profit (2017-2022)
-
Table Yongtai Pharmaceutical Intermediates Main Business and Markets Served
-
Table Yongtai Pharmaceutical Intermediates Product Portfolio
-
Table Lonza Company Details
-
Table Lonza Pharmaceutical Intermediates Sales, Price, Value and Gross Profit (2017-2022)
-
Table Lonza Pharmaceutical Intermediates Main Business and Markets Served
-
Table Lonza Pharmaceutical Intermediates Product Portfolio
-
Figure Global GMP Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Non-GMP Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Antibiotics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Antipyretic Analgesics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Vitamins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Pharmaceutical Intermediates Consumption Forecast by Country (2022-2028)
-
Table North America Pharmaceutical Intermediates Consumption Forecast by Country (2022-2028)
-
Figure United States Pharmaceutical Intermediates Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Pharmaceutical Intermediates Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Pharmaceutical Intermediates Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Pharmaceutical Intermediates Consumption Forecast by Country (2022-2028)
-
Figure Germany Pharmaceutical Intermediates Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Pharmaceutical Intermediates Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Pharmaceutical Intermediates Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Pharmaceutical Intermediates Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Pharmaceutical Intermediates Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Pharmaceutical Intermediates Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Pharmaceutical Intermediates Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Pharmaceutical Intermediates Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Pharmaceutical Intermediates Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Pharmaceutical Intermediates Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Pharmaceutical Intermediates Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Pharmaceutical Intermediates Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Pharmaceutical Intermediates Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Pharmaceutical Intermediates Consumption Forecast by Country (2022-2028)
-
Figure China Pharmaceutical Intermediates Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Pharmaceutical Intermediates Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Pharmaceutical Intermediates Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Pharmaceutical Intermediates Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Pharmaceutical Intermediates Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Pharmaceutical Intermediates Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Pharmaceutical Intermediates Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Pharmaceutical Intermediates Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Pharmaceutical Intermediates Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Pharmaceutical Intermediates Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Pharmaceutical Intermediates Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Pharmaceutical Intermediates Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Pharmaceutical Intermediates Consumption Forecast by Country (2022-2028)
-
Figure Brazil Pharmaceutical Intermediates Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Pharmaceutical Intermediates Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Pharmaceutical Intermediates Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Pharmaceutical Intermediates Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Pharmaceutical Intermediates Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Pharmaceutical Intermediates Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Pharmaceutical Intermediates Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Pharmaceutical Intermediates Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Pharmaceutical Intermediates Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Pharmaceutical Intermediates Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Pharmaceutical Intermediates Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Pharmaceutical Intermediates Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Pharmaceutical Intermediates Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Pharmaceutical Intermediates Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Pharmaceutical Intermediates Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Pharmaceutical Intermediates Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Pharmaceutical Intermediates Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Pharmaceutical Intermediates Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Pharmaceutical Intermediates Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Pharmaceutical Intermediates Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Pharmaceutical Intermediates Consumption Forecast by Country (2022-2028)
-
Figure Australia Pharmaceutical Intermediates Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Pharmaceutical Intermediates Consumption Forecast and Growth Rate (2022-2028)
-
